NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.19
-1.06 (-4.99%)
At close: Oct 13, 2026, 4:00 PM EDT
20.20
+0.01 (0.05%)
After-hours: Oct 13, 2026, 7:30 PM EDT
NAMS Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, NAMS stock has a consensus rating of "Strong Buy" and an average price target of $49.7. The average 1-year stock price forecast is 146.16% higher than the current stock price, while the lowest is $38.04 (+88.41%) and the highest is $59.32 (+193.81%).
Price Target: $49.7 (+146.16%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 12 | 12 | 12 | 12 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +108.02% | Oct 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +172.41% | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +157.55% | Sep 29, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $57 | Buy | Reiterates | $57 | +182.32% | Sep 22, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $58 | Buy | Maintains | $58 | +187.27% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
29.29M
from 22.50M
Increased by 30.15%
Revenue Next Year
141.78M
from 29.29M
Increased by 384.12%
EPS This Year
-1.96
from -1.72
EPS Next Year
-1.61
from -1.96
EPS and Forward PE are based on non-GAAP adjusted numbers.